v3.25.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated deficit
Accumulated other Comprehensive loss
Statutory reserves
Beginning balance (in shares) at Dec. 31, 2023   315,006,942        
Beginning balance at Dec. 31, 2023 $ 564,190 $ 32 $ 1,481,241 $ (897,501) $ (25,614) $ 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (126,381)     (126,381)    
Issuance of common stock in connection with vesting of share-based awards (in shares)   503,505        
Share-based compensation 24,011   24,011      
Issuance of warrants 779   779      
Foreign currency translation adjustments (7,611)       (7,611)  
Ending balance (in shares) at Jun. 30, 2024   315,510,447        
Ending balance at Jun. 30, 2024 454,988 $ 32 1,506,031 (1,023,882) (33,225) 6,032
Beginning balance (in shares) at Mar. 31, 2024   315,508,595        
Beginning balance at Mar. 31, 2024 546,146 $ 32 1,493,139 (922,326) (30,731) 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (101,556)     (101,556)    
Issuance of common stock in connection with vesting of share-based awards (in shares)   1,852        
Share-based compensation 12,113   12,113      
Issuance of warrants 779   779      
Foreign currency translation adjustments (2,494)       (2,494)  
Ending balance (in shares) at Jun. 30, 2024   315,510,447        
Ending balance at Jun. 30, 2024 $ 454,988 $ 32 1,506,031 (1,023,882) (33,225) 6,032
Beginning balance (in shares) at Dec. 31, 2024 323,144,134 323,144,134        
Beginning balance at Dec. 31, 2024 $ 387,895 $ 33 1,512,982 (1,092,958) (38,194) 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (44,268)     (44,268)    
Issuance of common stock in connection with vesting of share-based awards (in shares)   522,477        
Share-based compensation 1,549   1,549      
Foreign currency translation adjustments $ 10,954       10,954  
Ending balance (in shares) at Jun. 30, 2025 323,666,611 323,666,611        
Ending balance at Jun. 30, 2025 $ 356,130 $ 33 1,514,531 (1,137,226) (27,240) 6,032
Beginning balance (in shares) at Mar. 31, 2025   323,528,889        
Beginning balance at Mar. 31, 2025 454,235 $ 33 1,513,685 (1,031,168) (34,347) 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (106,058)     (106,058)    
Issuance of common stock in connection with vesting of share-based awards (in shares)   137,722        
Share-based compensation 846   846      
Foreign currency translation adjustments $ 7,107       7,107  
Ending balance (in shares) at Jun. 30, 2025 323,666,611 323,666,611        
Ending balance at Jun. 30, 2025 $ 356,130 $ 33 $ 1,514,531 $ (1,137,226) $ (27,240) $ 6,032